Sobi named UK’s top haemophilia company
Tops IPC Associates’ 2016 ranking
Read More
Author: Dominic Tyer
FDA to fast-track Pfizer/Sangamo gene therapy orphan drug
SB-525 is being developed to treat haemophilia A
Read More
Aspen Pharmacare hit by EU antitrust cancer drug price probe
European regulators will investigate pricing of five oncology treatments
Read More
NHS could save £67 million a year if smoking rates cut
But would need rates to drop to 5 percent
Read More
ReNeuron wins £1.8 million for cell therapy development
Innovate UK grant will help advance its manufacturing capabilities
Read More- SolasCure trial shows faster healing with Aurase Wound Gel
- Gilead data show investigational HIV combination maintains viral suppression
- Verdiva Bio completes enrolment for phase 2b study of oral GLP‑1 candidate VRB‑101
- MHRA approves imlunestrant tosylate as new breast cancer treatment
- ACD440 granted orphan drug status in the EU
